Aegera Therapeutics

Maple Bay, British Columbia, Canada

(514) 288-553 ★

http://www.aegera.com/

Company profile

Aegera Therapeutics company profile

Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials.

Business identity

Website: http://www.aegera.com/
Phone number: (514) 288-553
Operating status: Closed
Company type: For Profit
Employee range: 00011-00050 employees
Revenue range: $1K+
Founded: 1997-01-01

LinkedIn Facebook

Headquarters

Headquarters: Maple Bay, British Columbia, Canada
Postal code: H3E 1A8
Country code: CA
Continent: North America

Capital profile

Funding and company signals

Funding stage: M And A
Funding rounds: 3
Total equity funding: $29.2M
Last funding: Debt Financing / $6.4M / 2009-09-25
Last equity funding: Series C / $12.2M
Investors: 8
Lead investors: 2
Founders: 1
Articles: 1
Closed on: 2011-09-20
Exited on: 2011-05-27

Categories and groups

Biotechnology Health Care Pharmaceutical Biotechnology Health Care Science and Engineering

Founders and investors

Founders

Michael Atkin

Lead investors

GeneChemVenGrowth Asset Management

Investors

Business Development Bank of CanadaDesjardins Venture CapitalGeneChemGrowthWorks CapitalVenGrowth Asset Management

People at this company

Preview only. Contact details are available after you sign in.

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Shipment records and coverage can change as the dataset is updated.